

A Sativex lo mencionamos ayer.
En España iría con Almirall
In the rest of Europe, GW’s partner is Almirall and the Porton Down-headquartered firm noted that has amended its licensing deal with the Spanish group for the potential milestone payment to be received following this study result to reach £8 million. That is dependent on Almirall electing to include a country (probably Spain) as part of the forthcoming regulatory submission to the UK. This decision is expected to be made within the next month.
Mas...
Ver tambien...
No hay comentarios:
Publicar un comentario